期刊文献+

血管内皮生长因子与膜型基质金属蛋白酶-1在口腔鳞状细胞癌表达及意义 被引量:2

Expression of VEGF and MT1-MMP in Oral Squamous Cell Carcinoma and its Significance
原文传递
导出
摘要 [目的]检测血管内皮生长因子(VEGF)和膜型基质金属蛋白酶-1(MT1-MMP)在口腔鳞状细胞癌(OSCC)中的表达,并探讨其意义。[方法]采用免疫组织化学SP法检测VEGF、MT1-MMP在40例OSCC和10例口腔正常黏膜组织中的表达。[结果]VEGF和MT1-MMP在OSCC组织中的阳性表达率分别为67.50%和75.00%,在正常口腔黏膜组织中均阴性表达,差异有显著性(P<0.001)。VEGF表达与OSCC的临床分期(P<0.05)及淋巴结转移显著相关(P<0.01),与肿瘤的分化程度无关。MT1-MMP表达与OSCC的分化程度(P<0.05)及淋巴结转移显著相关(P<0.01),但与肿瘤的临床分期无相关性。VEGF与MT1-MMP表达呈正相关(rs=0.650,P<0.001)。[结论]VEGF与MT1-MMP在OSCC发生发展中起重要作用,共同促进OSCC的浸润转移。 [Purpose] To investigate the expression of vascular endothelial growth factor(VEGF) and membrane type 1 matrix metalloproteinase (MT1-MMP) in oral squamous cell carcinoma(OSCC) and its significance. [Methods] Immunohistochemical staining was used to detect the expression of VEGF and MT1-MMP in 40 cases with oral squamous cell carcinoma and 10 cases with oral normal mucosa. [Results] The positive rates of VEGF and MT1-MMP in OSCC were 67.50% and 75.00% respectively, while all negative in oral normal mueosa, the difference was significant (P〈0.001). The expression of VEGF in OSCC was related to clinical stages (P〈0.05) and lymph node metastasis (P〈 0.01), but not related to cancer differentiation. The expression of MT1-MMP in OSCC was related to the differentiation (P〈0.05) and lymph node metastasis (P〈0.01), but not related to the clinical stages. There was a close positive correlation between VEGF and MT1-MMP (rs=0.650,P〈0.001). [Conclusion] VEGF and MTI-MMP play an important role during carcinogenesis and development of OSCC. and thev accelerate the invasion and metastasis of OSCC.
出处 《肿瘤学杂志》 CAS 2009年第5期406-409,共4页 Journal of Chinese Oncology
基金 佳木斯大学科研立项课题(S2007-23)
关键词 血管内皮生长因子 膜型基质金属蛋白酶-1 口腔肿瘤 肿瘤 鳞状细胞 免疫组织化学 vascular endothelial growth factor membrane type 1 matrix metalloproteinase mouth neoplasm neoplasm, squamous cell immunohistochemistry
  • 相关文献

参考文献3

二级参考文献31

  • 1Folkman J.What is the evidence that tumors are angioge-nesis dependent? J Natl Cancer Inst,1990,82(1):4.
  • 2Plate KH,Breier G,Weich HA,et al.Vascular endothel-ial growth factor and glioma angiogenesis:coordinate induction of VEGF receptors,distribution of VEGF protein and possible in human gliomas in vivo regulatory mechanisms. Int J Cancer,1994,59(4):520-529.
  • 3Zagzag D.Angiogenic growth factors in neural embryog-enesis and neoplasia.Am J Pathl,1995,146(2):293-309.
  • 4Seetharam L, Gotoh N, Maru Y, et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor. Oncogene,1995,10(10):135-147.
  • 5Bosari S,Lee AK,Delellis RA,et al.Microvessel quanti-tation and prognosis in invasive breast carcinoma.Hum Pathol,1992,23(7):755-761.
  • 6Hanahan D,Folkman J.Patterns and emerging mechanis-ms of the angiogenic switch during tumorigenesis.Cell,1996,86(3):353-364.
  • 7Roychowdhury DF,Tseng AJr,Fu KK,et al.New progn-ostic factors in nasopharyngeal carcinoma:tumor angiog-enesis and C-erb B2 expression . Cancer , 1996 , 77(8): 1 419-1 426.
  • 8Takahashi Y,Kitadai Y,Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res, 1995,55(8):3 964-3 968.
  • 9Fong TA,Shawver LK,Sun L,et al.SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.Cancer Res,1999,59(1):99-106.
  • 10Barinaga M.Designing therapies that target tumor blood vessels.Scince,1997,275(5 299):482-484.

共引文献13

同被引文献30

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部